Bionet Capital Reinvestment Ratio
Bionet capital reinvestment ratio. Bionet (1784) has a Capital Reinvestment Ratio of 0.20x as of June 2026, meaning it reinvests 0% of its operating cash flow (NT$51.22 Million) in capital expenditures (NT$10.14 Million). Check total reinvestment intensity of Bionet to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Bionet (2019–2025)
Capital reinvestment ratio of Bionet from 2019 to 2025. This chart tracks Bionet's Capital Reinvestment Ratio across 7 annual periods. Also explore Bionet (1784) net asset momentum to track the company's year-over-year net asset growth rate.
Bionet Capital Reinvestment Ratio by Year (2019–2025)
Bionet capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see 1784 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.89x | NT$148.04 Million | NT$132.18 Million | ▲ +52.3% |
| 2024 | 0.59x | NT$176.49 Million | NT$103.49 Million | ▲ +241.5% |
| 2023 | 0.17x | NT$153.09 Million | NT$26.28 Million | ▼ -50.6% |
| 2022 | 0.35x | NT$94.65 Million | NT$32.91 Million | ▼ -71.0% |
| 2021 | 1.20x | NT$13.88 Million | NT$16.66 Million | ▲ +132.6% |
| 2020 | 0.52x | NT$73.66 Million | NT$38.03 Million | ▼ -88.1% |
| 2019 | 4.35x | NT$2.67 Million | NT$11.60 Million | — |